Classer les publications sur l'année
-
Biométrie et Analyses de bases de données/SNDS
Trends in the real-world management of patients with active relapsing-remitting multiple sclerosis treated with natalizumab (TYSABRIW) in France: An analysis of the PMSI database over five years (2019â2023)
LE PAGE E, EMERY C, FRAVALO A, FAGNANI F, CLEMENT A
Revue Neurologique ; 2025; 181 (535-543)
-
Parcours de Santé et Dispositifs innovantsSanté publique
Overview of migraine care, impact of the disease, and patient experience in France through patient voices: a cross-sectional and participatory survey study
DUBURCQ A, MOLINS M, DEBREMAEKER S, JOIE J, LOPES L, NEVORET C, BEGASSE DE DHAEM O
The Journal of Headache and Pain volume ; 2025; 26 (76)
-
Parcours de Santé et Dispositifs innovantsSanté publique
Trends in the real-world management of patients with active relapsing-remitting multiple sclerosis treated with natalizumab (TYSABRIÂź) in France: An analysis of the PMSI database over five years (2019-2023)
LE PAGE E, EMERY C, FRAVALO A, FAGNANI F, CLEMENT A
Revue neurologique ; 2025
-
Biométrie et Analyses de bases de données/SNDS
Treatment of myasthenia gravis in france: A retrospective claims database study (STAMINA)
TARD C, LAFORET P, DE POUVOURVILLE G, CROCHARD A, CHOLLET G, NEVORET C, BOUĂE S , SALORTâCAMPANA E.
Journal of Neurology ; 2024;271 (11:7239-7249)
-
Biométrie et Analyses de bases de données/SNDS
Epidemiology of myasthenia gravis in France: A retrospective claims database study (STAMINA).
SALORT-CAMPANA E, LAFORET P, DE POUVOURVILLE G, CROCHARD A, CHOLLET G, NEVORET C, EMERY C, BOUEE S, TARD C.
Rev Neurol ; 2023;
-
Santé publique
Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing.
MARCHADIER A, BEZANNIER L, BARRE-PIERREL S, MANCEAU A, ABADIE A, DETOURNAY B.
J Med Screen ; 2023;9691413231158932
-
Pharmaco-Epidémiologie
The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus.
DE SEZE J, SUCHET L, MEKIES C, MANCHON E, LABAUGE P, GUENNOC AM, DEFER G, CLAVELOU P, CASTELNOVO G, BOURRE B, BENSA-KOSCHER C, AL KHEDR A, LE MAO J, VILLEMUR L, BOUEE S, LUCIANI L, VERMERSCH P.
Neurol Ther ; 2023;12(2):351-369
-
Biométrie et Analyses de bases de données/SNDS
Epidemiology and disease burden of tuberous sclerosis complex in France: A population-based study based on national health insurance data
FAGNANI F, LAURENDEAU C, DE ZELICOURT M, MARSHALL J.
Epilepsia Open ; 2022;7(4):633-644
-
Biométrie et Analyses de bases de données/SNDS
An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014-2017
VERMERSCH P, SUCHET L, COLAMOARINO R, LAURENDEAU C, DETOURNAY B
Mult Scler Relat Disord ; 2020;46:102521
-
Ăconomie de la santĂ©
Economic burden of multiple sclerosis in France estimated from a regional medical registry and national sick fund claims.
DETOURNAY B, DEBOUVERIE M, PEREIRA O, SEYER D, SOUDAN M, COUROUVE L, JHOMA K, EPSTEIN J, GUILLEMIN F.
Mult Scler Relat Disord ; 2019;36:101396
-
Biométrie et Analyses de bases de données/SNDS
Migraine burden and costs in france: a nationwide claims database analysis of triptan users.
DONNET A, EMERY C, ALY S, ALLAF B, CAYRE F, MAHIEU N, GOURMELEN J, LEVY P, FAGNANI F.
J Med Econ ; 2019;22(7):616-624
-
Ăconomie de la santĂ©
Multiple Source of Information to Characterize the Clinical, Therapeutic Management and Economic Burden of Patients with Multiple Sclerosis in France.
EPSTEIN J, DETOURNAY B , GUILLEMIN F, DEBOUVERIE M, COUSIN M, TEHARD B, GAROT T, BITOUN L, SOUDANT M , DEPOORTERE PH, PAU D
Value in Health ; 2017;20(9):a719
-
Ăconomie de la santĂ©
Effect of Multiple Sclerosis on Work Productivity
DETOURNAY B, COUSIN M, GOURMELEN J, PAU D, PINGUET JM, TEHARD B, COZZONE D
Value in Health ; 2017;20(9):a725
-
Ăconomie de la santĂ©
Effect of Multiple Sclerosis on Work Productivity
DETOURNAY B, COUSIN M, GOURMELEN J, PAU D, PINGUET JM, TEHARD B, COZZONE D
Value in Health ; 2017;20(9):a725
-
Ăconomie de la santĂ©
The Direct Cost of Patients With Multiple Sclerosis In France
DETOURNAY B, COUSIN M, GOURMELEN J, L. BITOUN L, PAU D, COZZONE D, B. TEHARD B
Value in Health ; 2017;20(9):a721
  Â